8 Results for "

Lymphopenia

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Lymphopenia" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-149004
CAS No.: 2763730-97-6
Purity:  98.02%
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

SLF1081851 is a Spns2 inhibitor, inhibits S1P release (IC50=1.93 μM). SLF1081851 plays a key role in development and immune system .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150254A
Purity:  99.91%
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

SLB1122168 formic is a Spinster Homolog 2 (Spns2) inhibitor. SLB1122168 formic inhibits Spns2-mediated sphingosine-1-phosphate (S1P) release with an IC50 of 94 nM. SLB1122168 formic induces lymphopenia in circulating lymphocytes in mice and rats .
loading...
    loading...
Cat. No.: HY-18164
CAS No.: 945725-50-8
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

TASP0277308 is a highly selective S1P1 antagonist. TASP0277308 possesses immunomodulatory activities, including lymphopenia, a block in T cell egress from the thymus, marginal zone B cell displacement, and the upregulation of CD69 expression on lymphocytes. TASP0277308 can be used for the research of collagen-induced arthritis in mice .
loading...
    loading...
Cat. No.: HY-132847
CAS No.: 1403232-33-6
Purity:  99.52%
Synonyms: SCD-044
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

Vibozilimod (SCD-044) is an oral S1P1/EDG1 receptor-selective agonist with an EC50 of <1 nM. Vibozilimod promotes S1P1/EDG1 receptor internalization, inhibits lymphocyte migration, induces lymphopenia and reduces lymphocyte counts. Vibozilimod is used for the research of inflammatory diseases such as psoriasis and atopic dermatitis .
loading...
    loading...
Cat. No.: HY-150254
CAS No.: 2999629-17-1
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

SLB1122168 is a Spinster Homolog 2 (Spns2) inhibitor. SLB1122168 inhibits Spns2-mediated sphingosine-1-phosphate (S1P) release with an IC50 of 94 nM. SLB1122168 induces lymphopenia in circulating lymphocytes in mice and rats .
loading...
    loading...
Cat. No.: HY-107122
CAS No.: 1021539-02-5
MK-5932 is an orally active, selective, dissociated partial glucocorticoid receptor agonist. MK-5932 inhibits IL-6. MK-5932 induces lymphopenia. MK-5932 restores glucose levels to normal. MK-5932 shows anti-inflammatory effects .
loading...
    loading...
Cat. No.: HY-16621
CAS No.: 911412-31-2
Target:  

SphK

Research Areas:  

Inflammation/Immunology

PPI-4955 is a subtype 1 (S1P₁) agonist of sphingosine-1-phosphate receptor with an EC50 of 1.62 nM. PPI-4955-P (the active phosphorylated form) exhibits excellent receptor selectivity and affinity, and the IC50 values for hS1P₁, hS1P₃, hS1P₄, and hS1P₅ are 0.23, 2000, 6.5, and 184 nM respectively. PPI-4955 has significantly improved in vivo phosphorylation efficiency, which can reduce lymphocytes and improve cardiovascular risk. PPI-4955 can be used in immunomodulation research .
loading...
    loading...
Cat. No.: HY-182375A
CAS No.: 2764877-95-2
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology Cancer

SLB1122168 free base is a Spinster Homolog 2 (Spns2) inhibitor. SLB1122168 free base inhibits Spns2-mediated sphingosine-1-phosphate (S1P) release with an IC50 of 94 nM. SLB1122168 free base induces lymphopenia in circulating lymphocytes in mice and rats .
loading...
    loading...